Lemoncat that "phase 3 ready drug" I believe is still not in phase 3 after 18 months..hmmm? I also believe that drug is for 1 type of hnc cancer(15k-20k patients) and that is why the tablet is placed behind the lip for "hours" every day(that's gotta be annoying). It has to do with the saliva production or some crap. Anyway what I'm getting at is this drug sounds like a piece of crap that could be picked up for let's say $1mm.
If leo is looking at getting Absssi in to P3 then I think the deal far exceeds $100mm upfront. P3 for absssi is $30mm itself.
Then you throw in B-om($15mm?)/K-p2b , b-eczema p2 b-acne P2 ,B-Crohns P2 and B-UC P2 you are talking a whole lotta money.
100mm ain't gonna cut it...simple as that...
No way with this pipeline should IPIX currently be at .10
But that's about to change imo.
(2)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links